Filing Flows › Sonoma Pharmaceuticals (SNOA) › Q1 FY27 › vs Q4 FY26
Sonoma Pharmaceuticals (SNOA) Q1 FY27 vs Q4 FY26 (quarter over quarter)
Sonoma Pharmaceuticals's revenue rose $845K (+15%) from $5.6M in Q4 FY26 to $6.4M in Q1 FY27.
Sonoma Pharmaceuticals, Q1 FY27: revenue $6.4M (+60% year over year), operating margin -0.6%, net loss $330K, operating cash flow −$649K. The chart draws each line against Q4 FY26, the increases inside each band.
Every line
| Line | Q1 FY27 | Q4 FY26 | Change | % |
|---|---|---|---|---|
| Revenue | $6.4M | $5.6M | $845K | +15% |
| Net loss | $330K | $581K | −$251K | -43% |
| Costs & expenses | $6.7M | $6.1M | $594K | +10% |
| Operating costs | $6.4M | $5.9M | $534K | +9% |
| Interest & other, net | $290K | $146K | $144K | +99% |
| Cost of revenue | $3.8M | $3.4M | $449K | +13% |
| Research & development | $597K | $545K | $52K | +10% |
| SG&A | $2.0M | $2.0M | $33K | +2% |
| Operating cash sources | $739K | $687K | $52K | +8% |
| Depreciation & amortization | $32K | $33K | −$1K | -3% |
| Share-based compensation | $58K | $135K | −$77K | -57% |
| Cash used in operations | $649K | $519K | $130K | +25% |
| Net loss absorbed | $330K | $581K | −$251K | -43% |
| Working capital & other | $409K | $106K | $303K | +286% |
Questions
How much did Sonoma Pharmaceuticals's revenue grow quarter over quarter in Q1 FY27?
Sonoma Pharmaceuticals's revenue rose $845K (+15%) from $5.6M in Q4 FY26 to $6.4M in Q1 FY27.